Overview

Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this Phase 1 crossover study is to evaluate the neuropsychological effects of Lacosamide (LCM) compared to Carbamazepine Immediate Release (CBZ-IR) after administration in healthy subjects. Safety, tolerability, and pharmacokinetic data will also be collected.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Pharma
Treatments:
Carbamazepine
Lacosamide